Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Zentalis Pharmaceuticals (ZNTL) Shares Issued (2022 - 2026)

Zentalis Pharmaceuticals has reported Shares Issued over the past 5 years, most recently at $331000.0 for Q1 2026.

  • For Q1 2026, Shares Issued rose 75.13% year-over-year to $331000.0; the TTM value through Mar 2026 reached $5.5 million, up 1807.59%, while the annual FY2025 figure was $5.4 million, 1444.41% up from the prior year.
  • Shares Issued for Q1 2026 was $331000.0 at Zentalis Pharmaceuticals, down from $5.1 million in the prior quarter.
  • Over five years, Shares Issued peaked at $234.1 million in Q4 2023 and troughed at -$206.2 million in Q4 2022.
  • A 5-year average of $15.8 million and a median of $320000.0 in 2023 define the central range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 213.52% in 2023 and fell as far as 99.49% in 2023.
  • Year by year, Shares Issued stood at -$206.2 million in 2022, then soared by 213.52% to $234.1 million in 2023, then crashed by 99.96% to $92000.0 in 2024, then surged by 5428.26% to $5.1 million in 2025, then tumbled by 93.49% to $331000.0 in 2026.
  • Business Quant data shows Shares Issued for ZNTL at $331000.0 in Q1 2026, $5.1 million in Q4 2025, and $115000.0 in Q3 2025.